Pharma Focus Asia

Vazyme Enters into Global Strategic Collaboration Agreement with Azenta

Saturday, July 01, 2023

Vazyme and Azenta Life Sciences have recently announced a global strategic cooperation agreement. 

This collaboration aims to establish a comprehensive "one-stop" service process for both companies in various fields, including next-generation sequencing, automated library preparation, raw material supply, experimental consumables, sample storage, and more. The agreement signifies a commitment to jointly provide enhanced services and solutions to their customers in these areas.

Vazyme and Azenta are committed to future collaborations in several key areas. These include automated sample solutions, oligo synthesis, molecular biology services, and GLP standard specification services. With the integration of respective resources and strengths, both companies aim to drive innovation and achieve significant advancements in these fields. 

They will work together to develop international markets and make substantial contributions to improving the quality of life and health for people worldwide. The joint efforts of Vazyme and Azenta will pave the way for transformative breakthroughs and foster positive impacts on a global scale.
 

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024